Treatment of vaginal atrophy in women with a risk of cardiovascular disease

RESPECT THE INVENTION USING ESTRIOL IN THE PREPARATION OF PHARMACEUTICAL FORMULATION FOR ADMINISTRATION VAGINALE HAVING THE ABILITY TO SELF-LIMITING ABSORPTION ESTRIOL. THAT AIMS TO PREPARE THE PREVENTION AND / OR TREATMENT OF ATROPHY UROGENITAL AMONG WOMEN WITH HIGH PROBABILITY TO BE SUFFERING FROM CARDIOVASCULAR DISEASE, OR SUFFER OR HAVE SUFFERED OF A CARDIOVASCULAR DISEASE.